Are you a member of the press? Visit Our Press Kit
Does Neuromodulation Using Baroreflex Activation Therapy (BAT) have Potential Application in HFpEF?
News release: CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes
News release: CVRx® Announces Publication of BeAT-HF Clinical Study Results in the Journal of The American College of Cardiology